Vivani Medical (VANI) Projected to Post Quarterly Earnings on Monday

Vivani Medical (NASDAQ:VANI - Get Free Report) is expected to post its Q1 2025 quarterly earnings results before the market opens on Monday, May 12th. Analysts expect Vivani Medical to post earnings of ($0.10) per share for the quarter.

Vivani Medical (NASDAQ:VANI - Get Free Report) last posted its earnings results on Monday, March 31st. The company reported ($0.11) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.01). On average, analysts expect Vivani Medical to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Vivani Medical Trading Up 1.5 %

Shares of VANI stock traded up $0.02 on Friday, hitting $1.04. The stock had a trading volume of 17,180 shares, compared to its average volume of 165,813. The firm has a market cap of $61.32 million, a P/E ratio of -2.30 and a beta of 2.81. Vivani Medical has a twelve month low of $0.91 and a twelve month high of $2.09. The company has a fifty day moving average price of $1.05 and a two-hundred day moving average price of $1.17.

Analysts Set New Price Targets

Separately, HC Wainwright reaffirmed a "buy" rating and set a $4.00 price target on shares of Vivani Medical in a research report on Wednesday, April 16th.

Insider Buying and Selling at Vivani Medical

In related news, Director Gregg Williams acquired 34,000 shares of the stock in a transaction dated Friday, April 4th. The stock was bought at an average price of $0.99 per share, with a total value of $33,660.00. Following the completion of the transaction, the director now directly owns 4,754,800 shares of the company's stock, valued at approximately $4,707,252. The trade was a 0.72 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Over the last quarter, insiders have purchased 108,922 shares of company stock valued at $108,769. 44.30% of the stock is currently owned by corporate insiders.

Vivani Medical Company Profile

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.